Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Fuyuan Pharmaceutical is a prominent Chinese pharmaceutical company and a core subsidiary of Huadong Medicine. The company specializes in the research, development, and large-scale manufacturing of high-quality generic and innovative small molecule drugs, with a strong focus on chronic disease management. Its primary therapeutic areas include cardiovascular health, metabolic disorders (specifically diabetes), and neuropsychiatry. Fuyuan operates advanced GMP-certified manufacturing facilities and maintains a robust commercial presence across China, supplying essential medications such as metformin and various antihypertensive agents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fuyuan Pharmaceutical.